GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » InnovAge Holding Corp (NAS:INNV) » Definitions » Days Sales Outstanding

INNV (InnovAge Holding) Days Sales Outstanding : 21.06 (As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is InnovAge Holding Days Sales Outstanding?

InnovAge Holding's average Accounts Receivable for the three months ended in Dec. 2024 was $48.2 Mil. InnovAge Holding's Revenue for the three months ended in Dec. 2024 was $209.0 Mil. Hence, InnovAge Holding's Days Sales Outstanding for the three months ended in Dec. 2024 was 21.06.

The historical rank and industry rank for InnovAge Holding's Days Sales Outstanding or its related term are showing as below:

INNV' s Days Sales Outstanding Range Over the Past 10 Years
Min: 15.98   Med: 20.23   Max: 40.22
Current: 20.32

During the past 6 years, InnovAge Holding's highest Days Sales Outstanding was 40.22. The lowest was 15.98. And the median was 20.23.

INNV's Days Sales Outstanding is ranked better than
80.12% of 654 companies
in the Healthcare Providers & Services industry
Industry Median: 46.8 vs INNV: 20.32

InnovAge Holding's Days Sales Outstanding declined from Dec. 2023 (21.17) to Dec. 2024 (21.06).


InnovAge Holding Days Sales Outstanding Historical Data

The historical data trend for InnovAge Holding's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

InnovAge Holding Days Sales Outstanding Chart

InnovAge Holding Annual Data
Trend Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Days Sales Outstanding
Get a 7-Day Free Trial 31.41 22.57 17.89 15.98 17.31

InnovAge Holding Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 21.17 18.88 19.35 21.09 21.06

Competitive Comparison of InnovAge Holding's Days Sales Outstanding

For the Medical Care Facilities subindustry, InnovAge Holding's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


InnovAge Holding's Days Sales Outstanding Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, InnovAge Holding's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where InnovAge Holding's Days Sales Outstanding falls into.


;
;

InnovAge Holding Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

InnovAge Holding's Days Sales Outstanding for the fiscal year that ended in Jun. 2024 is calculated as

Days Sales Outstanding (A: Jun. 2024 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Jun. 2023 ) + Accounts Receivable (A: Jun. 2024 )) / count ) / Revenue (A: Jun. 2024 )*Days in Period
=( (24.344 + 48.106) / 2 ) / 763.855*365
=36.225 / 763.855*365
=17.31

InnovAge Holding's Days Sales Outstanding for the quarter that ended in Dec. 2024 is calculated as:

Days Sales Outstanding (Q: Dec. 2024 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Sep. 2024 ) + Accounts Receivable (A: Dec. 2024 )) / count ) / Revenue (A: Dec. 2024 )*Days in Period
=( (46.735 + 49.759) / 2 ) / 208.999*365 / 4
=48.247 / 208.999*365 / 4
=21.06

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


InnovAge Holding  (NAS:INNV) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


InnovAge Holding Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of InnovAge Holding's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


InnovAge Holding Business Description

Traded in Other Exchanges
N/A
Address
8950 East Lowry Boulevard, Denver, CO, USA, 80230
InnovAge Holding Corp is a healthcare delivery platform by several participants focused on providing all-inclusive, capitated care to high-cost, dual-eligible seniors. Its patient-centered care delivery approach improves the quality of care while keeping them in their homes and reducing over-utilization of high-cost care settings such as hospitals and nursing homes. The company's segment includes PACE and others. It generates maximum revenue from the PACE segment.
Executives
Nicole Damato officer: CHIEF LEGAL OFFICER 8950 E. LOWRY BOULEVARD, DENVER CO 80230
Teresa Sparks director 40 BURTON HILLS BOULEVARD SUITE 500, NASHVILLE TN 37215
Benjamin C Adams officer: CHIEF FINANCIAL OFFICER 8950 E. LOWRY BOULEVARD, DENVER CO 80230
Patricia Fontneau director 8950 E. LOWRY BOULEVARD, DENVER CO 80230
Christine Bent officer: CHIEF OPERATIONS OFFICER 8950 E. LOWRY BOULEVARD, DENVER CO 80230
Thomas Scully director 320 PARK AVENUE, SUITE # 2500, NEW YORK NM 10022
Richard Feifer officer: CHIEF MEDICAL OFFICER C/O GENESIS HEALTHCARE, INC., 101 EAST STATE STREET, KENNETT SQUARE PA 19348
James G Carlson director 8950 E. LOWRY BOULEVARD, DENVER CO 80230
Patrick T Blair officer: PRESIDENT 8950 E. LOWRY BOULEVARD, DENVER CO 80230
Caroline Dechert director 580 CALIFORNIA ST., SUITE 1700, SAN FRANCISCO CA 94104
Pavithra Mahesh director 601 LEXINGTON AVE., 53RD FLOOR, NEW YORK NY 10022
Maureen Hewitt director, officer: CEO, President and Director 8950 E. LOWRY BLVD., DENVER CO 80230
Maria Lozzano officer: CORPORATE COO 8950 E. LOWRY BLVD., DENVER CO 80230
Robin Doerr officer: CHIEF SALES AND MKTG. OFFICER 8950 E. LOWRY BLVD., DENVER CO 80230
Melissa Welch officer: CHIEF MEDICAL OFFICER 8950 E. LOWRY BLVD., DENVER CO 80230